OrderlyMeds has announced that it is accepting more patients into its online weight loss program, making GLP-1 injections more accessible.
-- OrderlyMeds has announced that it is accepting more patients into its online weight loss programs, which are offered as a convenient alternative to in-person treatments.
For more information, please visit https://orderlymeds.com/
The GLP-1 hormone is released by the small intestine when food passes through the digestive system. This hormone triggers insulin release from the pancreas, blocks the secretion of glucagon, and slows the emptying of the stomach so less glucose is released from food into the bloodstream - effects that all play a role in lowering blood sugar levels after eating. Additionally, GLP-1 affects areas of the brain that process hunger, prolonging feelings of satiety and keeping individuals fuller for longer.
As OrderlyMeds explains, glucagon-like peptide-1 agonists, commonly abbreviated to GLP-1 agonists, are a class of medications, usually injectable, that mimic these effects. They are most often prescribed to regulate blood sugar levels in individuals with type 2 diabetes, but more recently, they have been used to manage unhealthy weight gain and obesity due to their ability to suppress appetite. GLP-1 medications are also approved for use in many weight loss treatments, including the ones that OrderlyMeds offers.
Individuals who enroll in OrderlyMeds’ programs will receive a personalized GLP-1 treatment plan developed based on a detailed evaluation of their health history by a licensed medical provider. Possible options include Wegovy and Zepbound, but compounded GLP-1 and GLP-1/GIP medications are also available; these medications are more cost-effective than their brand-name alternatives, but they will only be prescribed when it is deemed medically appropriate by the patient’s physician.
Regardless of the choice, medications will be shipped to the customer’s address, ensuring they can complete treatment from the comfort of their home. For the first three months, the medication dosage will be increased steadily as the patient’s body adjusts; the next three months will focus on integrating lifestyle changes, including dietary adjustments and physical activity recommendations. After six months, patients will be given the opportunity to evaluate their progress and adjust their weight loss goals, and beyond month 10, treatment focus will shift to sustaining whole-body health over the long term.
More information is available at https://orderlymeds.com/
Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/
Source: PressCable
Release ID: 89185484
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.
